EUS-guided portal injection chemotherapy for treatment of hepatic metastases: Feasibility in the acute porcine model

Douglas O. Faigel, Douglas Lake, Tracy L. Landreth, Catherine C. Kelman, Ronald J. Marler

Research output: Contribution to journalArticle

13 Scopus citations

Abstract

Background and Aims Direct injection of chemotherapy into the portal vein for treatment of liver metastases may increase hepatic tissue levels while decreasing systemic levels and toxicities. We aimed to evaluate EUS-guided portal injection chemotherapy (EPIC) by using drug-eluting microbeads or nanoparticles and compare it with systemic injection. Methods We conducted a comparative feasibility trial in the acute porcine model (24 anesthetized pigs). Pigs were treated with irinotecan, doxorubicin, or albumin-bound paclitaxel nanoparticles (n = 8/group). Within each group, pigs were treated with EPIC or a systemic intravenous injection of drug and saline solution into the portal vein (n = 4/treatment). Irinotecan or doxorubicin were loaded onto microbeads for EPIC treatment only. We examined drug levels in tissue (1 hour) and plasma (15 minutes). Results EUS-guided access and injection was successful in all animals. EPIC with irinotecan-loaded microbeads showed nearly double the hepatic concentration compared with systemic injection (6242 vs 3692 ng/g) and almost half the systemic levels. EPIC with doxorubicin-loaded microbeads showed a 5-fold increase in hepatic levels (35,450 vs 6930 ng/g) and a 30-fold decrease in cardiac levels (153 vs 4805 ng/g) compared with systemic administration (P

Original languageEnglish (US)
Pages (from-to)444-446
Number of pages3
JournalGastrointestinal Endoscopy
Volume83
Issue number2
DOIs
StatePublished - Feb 1 2016

ASJC Scopus subject areas

  • Gastroenterology
  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'EUS-guided portal injection chemotherapy for treatment of hepatic metastases: Feasibility in the acute porcine model'. Together they form a unique fingerprint.

  • Cite this